SESSION TITLE: Sarcoidosis
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Wednesday, October 26, 2016 at 07:30 AM - 08:30 AM
PURPOSE: Cardiac sarcoidosis (CS) is a potentially life-threatening cardiomyopathy, although limited data exist to guide pharmacotherapy. Corticosteroids presently constitute the mainstay of treatment, but are associated with significant toxicities. Mycophenolate mofetil (MMF) is a corticosteroid-sparing agent that may have a role in management of CS.